Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2012

Aug 14, 2012

35106_dirs_2012-08-14_c775f6c6-652d-472a-a0c4-e6ef0207b5a6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioDrain Medical, Inc. (BIOR)
CIK: 0001446159
Period of Report: 2012-08-13

Reporting Person: MYERS ROBERT L (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-13 Stock Options (right to buy) $0.08 A 1000000 Acquired 2022-08-13 Common Stock (1000000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 0 Direct

Footnotes

F1: 700,000 shares vest immediately; 300,000 shares vest on 2/13/2014.